Display options
Cite
Madaan M, Puri M, Sharma R, et al. Unusually High Levels of CA19-9 Associated with Mature Cystic Teratoma of the Ovary. Case Rep Obstet Gynecol. 2014;2014:187910doi: 10.1155/2014/187910.
Madaan, M., Puri, M., Sharma, R., Kaur, H., & Trivedi, S. S. (2014). Unusually High Levels of CA19-9 Associated with Mature Cystic Teratoma of the Ovary. Case reports in obstetrics and gynecology, 2014187910. https://doi.org/10.1155/2014/187910
Madaan, Monika, et al. "Unusually High Levels of CA19-9 Associated with Mature Cystic Teratoma of the Ovary." Case reports in obstetrics and gynecology vol. 2014 (2014): 187910. doi: https://doi.org/10.1155/2014/187910
Madaan M, Puri M, Sharma R, Kaur H, Trivedi SS. Unusually High Levels of CA19-9 Associated with Mature Cystic Teratoma of the Ovary. Case Rep Obstet Gynecol. 2014;2014:187910. doi: 10.1155/2014/187910. Epub 2014 Sep 08. PMID: 25276448; PMCID: PMC4170748.
Copy Download .nbib Format: NLM
Share it on

Case Rep Obstet Gynecol. 2014;2014:187910. doi: 10.1155/2014/187910. Epub 2014 Sep 08.

Unusually High Levels of CA19-9 Associated with Mature Cystic Teratoma of the Ovary.

Case reports in obstetrics and gynecology

Monika Madaan, Manju Puri, Ritu Sharma, Harvinder Kaur, Shubha Sagar Trivedi

Affiliations

  1. LHMC and SSKH, New Delhi 110001, India ; ESIC Hospital, Manesar, Haryana 122001, India.
  2. LHMC and SSKH, New Delhi 110001, India.

PMID: 25276448 PMCID: PMC4170748 DOI: 10.1155/2014/187910

Abstract

Introduction. Mature cystic teratoma is the benign tumor of the ovary. CA19-9 levels, although a marker of pancreatic malignancy, have been found to be raised in large ovarian mature cystic teratomas. Case Report. We report a case of a young female who had unusually high levels of CA19-9 in the blood associated with large ovarian mature cystic teratoma. The levels returned to normal 12 weeks after cystectomy was performed. Conclusion. This case highlights the fact that although raised tumor marker may be associated with a benign pathology thorough evaluation to rule out malignancy still must be done.

References

  1. Am J Gastroenterol. 1990 Apr;85(4):350-5 - PubMed
  2. BMJ Case Rep. 2009;2009: - PubMed
  3. Clin Exp Obstet Gynecol. 2008;35(2):137-9 - PubMed
  4. Int J Gynaecol Obstet. 2005 Dec;91(3):262-3 - PubMed
  5. Cancer. 1998 Jun 1;82(11):2249-55 - PubMed

Publication Types